Topics

Camurus AB Company Profile

13:23 EDT 18th July 2019 | BioPortfolio

Camurus is a drug delivery company, within the healthcare sector, that specializes in formulation technologies of sparingly water soluble drug substances. Camurus offer proprietary technology platforms that enable customers to extend product life cycles or optimize patent protection for new products.

Location

Ideon Science ParkSölvegatan 41
Lund
SE-223 70
Sweden

Contact

Phone: +46 (0)46 286 57 30
Fax: +46 (0)46 286 57 39
Email: info@camurus.com


News Articles [15 Associated News Articles listed on BioPortfolio]

Camurus AB: US FDA Issues A Tentative Approval of Brixadi™ (buprenorphine) Extended-release ...

LUND, Sweden, Dec. 23, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) has issued Camurus' US Read more...

Camurus AB: US FDA Issues A Tentative Approval of Brixadi (buprenorphine) Extended-release Injection for Treatment of Opioid Use Disorder

LUND, Sweden, Dec. 23, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the US Food and Drug Administration (FDA) has issued Camurus' US partner Braeburn a tentative approval o...

Camurus - Full Year Report 2018

STOCKHOLM, Feb. 6, 2019 /PRNewswire/ -- "The approval of Buvidal is a major milestone for Camurus and an important validation of our innovative FluidCrystal technology." Business highlights fourth...

Camurus, Braeburn's opioid use disorder drug nabs tentative FDA nod

Camurus and Braeburn's Brixadi, or buprenorphine, extended-release injection for weekly and monthly subcutaneous use in patie -More- 

Camurus Receives IND Acceptance From the FDA to Enter Phase 3 with CAM2029 for Treatment of Acromegaly

LUND, Sweden, June 20, 2019 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX), a commercial stage biopharmaceutical company specializing in long-acting medicines for severe and chronic disorders, announc...

Camurus to Present Full Year 2018 Results on 6 February

LUND, Sweden, Feb. 1, 2019 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the Company will release its full year report on 6 February at 7:00 am CET. The report will be available ...

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares in Camurus AB (30/19)

With effect from March 11, 2019, the subscription rights in Camurus AB will be quoted on the list for Equity rights. Quotation will continue up until and including March 21, 2019. Instrument: Subsc...

Lovande behandling mot fentanylmissbruk

Camurus redovisar fas 3-data för Buvidal.

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Local analgesic effect of a bioadhesive barrier-forming oral liquid in cancer patients with oral mucositis caused by chemotherapy and/or radiotherapy: a randomized multicenter, single-use, positive-controlled, open-label study.

CAM2028 (Episil; Camurus AB, Lund, Sweden) is a liquid for use in the oral cavity to treat various pains associated with mouth injuries. Upon contact with the swollen oral mucosa, the oral liquid form...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Camurus AB

Camurus is a drug delivery company, within the healthcare sector, that specializes in formulation technologies of sparingly water soluble drug substances. Camurus offer proprietary technology platform...

Ra Pharmaceuticals and Camurus AB

Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Co...

Solasia Pharma K.K. and Camurus AB

Solasia was formed in November 2006 by MPM Capital and ITOCHU Corporation to address unmet needs for important new Western oncology therapies and supportive care products througho...

More Information about "Camurus AB" on BioPortfolio

We have published hundreds of Camurus AB news stories on BioPortfolio along with dozens of Camurus AB Clinical Trials and PubMed Articles about Camurus AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Camurus AB Companies in our database. You can also find out about relevant Camurus AB Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record